SCHEMBL7535896

SCHEMBL7535896

CON=C(c1cc(C)no1)c1ccccc1COc1cc(C)ccc1C

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.40
▸ RAB9A P51151 6/20 0.39
▸ NPC1 O15118 5/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ AKR1C3 P42330 2/20 0.37
▸ BRD4 O60885 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ CASP3 P42574 1/20 0.35
▸ SENP8 Q96LD8 1/20 0.35
▸ SENP7 Q9BQF6 1/20 0.35
▸ SENP6 Q9GZR1 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7537223 0.83 RAB9A (0.43) MAPTRAB9ANPC1KMT2AALDH1A1
SCHEMBL7541677 0.83 ALDH1A1 (0.38) MAPTRAB9ANPC1KMT2AALDH1A1
SCHEMBL7535399 0.82 RAB9A (0.39) MAPTRAB9ANPC1KMT2AALDH1A1
SCHEMBL7535134 0.81 KMT2A (0.41) MAPTRAB9ANPC1KMT2AALDH1A1
SCHEMBL7542538 0.80 KMT2A (0.41) RAB9ANPC1KMT2AALDH1A1SMN1; SMN2
SCHEMBL7537180 0.79 KMT2A (0.41) RAB9ANPC1KMT2AALDH1A1SMN1; SMN2
SCHEMBL7538368 0.79 MAPT (0.36) MAPTRAB9ANPC1KMT2AALDH1A1
SCHEMBL7535933 0.77 SMN1; SMN2 (0.42) MAPTRAB9ANPC1KMT2AALDH1A1
SCHEMBL7535938 0.77 SMN1; SMN2 (0.42) MAPTRAB9ANPC1KMT2AALDH1A1
SCHEMBL7537475 0.77 SMN1; SMN2 (0.38) MAPTRAB9ANPC1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6362212-B1 POTENT FUNGICIDAL ACTIVITY SHIONOGI & COMPANY, LTD. (JP) 2002-03-26 — — US disclosed
US-20020032227-A1 Oxime derivative and bactericide containing the same as active ingredient TAKASE AKIRA (JP) 2002-03-14 — — US disclosed
US-6268312-B1 FUNGICIDES SHIONOGI & CO., LTD. (JP) 2001-07-31 — — US disclosed
US-6048885-A FUNGICIDES SHIONOGI & CO., LTD. (JP) 2000-04-11 — — US disclosed
EP-0754684-A1 OXIME DERIVATIVE AND BACTERICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT SHIONOGI & CO., LTD. (JP) 1997-01-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032227-A1 Oxime derivative and bactericide containing the same as active ingredient MSMO1, O60361, CBR1 MAPT 4733/4885RAB9A 3734/4885NPC1 3604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback